PTC THERAPEUTICS, INC. — Director's Dealing 2014

Sep 16, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-09-15

Reporting Person: Rothera Mark (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-15	Common Stock	S	3000	$36.68	Disposed	22000	Direct
2014-09-15	Common Stock	S	3160	$35.72	Disposed	18840	Direct
2014-09-15	Common Stock	S	1840	$36.41	Disposed	17000	Direct

Footnotes

F1: The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 21, 2013, as amended on March 17, 2014 and August 12, 2014.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $36.40 to $37.30 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $35.05 to $36.02 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F4: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $36.21 to $36.53 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.